Schedule 13G ownership disclosure
Kura Oncology Inc
Security class unavailable · CUSIP: 50127T109
Event date: 2024-11-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-125975
- Form type
- SC 13G
- Filer
- Kura Oncology, Inc.
- CIK
- CIK 1422143
- Filed
- Dec 05, 2024
- Reporting period
- Nov 27, 2024
- Description
- Schedule 13G beneficial ownership